Skip directly to content


Celebrex®, the only FDA-approved oral COX-2 inhibitor1, is the worldwide No.1 most prescribed COX-2 inhibitor2. With indications for relieving acute pain or chronic pain symptoms such as low back pain, joint pain and menstrual pain3, Celebrex® is proven by a number of worldwide, large-scale clinical trials that it has a low risk of gastrointestinal adverse events comparing to traditional NSAIDsplus gastroprotective agents5, and it is as effective as traditional NSAID4,5.


  1. Sharon Hertz, FDA Consumer Health Information, US, FA, Sep 2015.
  2. Celebrex®(celecoxib) IQVIAS MIDAS Sales Data 2019 Q1 MAT.
  3. Celebrex®(celecoxib) 100mg, 200mg, 400mg Prescribing information. Pfizer Corporation Hong Kong Limited: Version August 2018.
  4. McKenna F, Borenstein D, Wendt H, et al. Scand J Rheumatol 2001;30:11-18.
  5. Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL. Lancet. 2010;376:173-179.
[PP-CPF-HKG-0060] SEP 2019